According to this study, TOB1 interacted with another tumor suppressor protein, SMAD4, and enhanced the binding of SMAD4 to the SMAD binding element (SBE) located on the promoter region of IL-2, thereby dampening IL-2 transcription. The gene discussed is IL2; the disease is neoplasm.